| MR编号 | NL/H/5324/001 |
|---|
| 药品名称 | Luvify 0.25 mg/ml, oplossing, oogdruppels |
|---|
| 活性成分 | - brimonidine tartrate 0.25 mg/ml
|
|---|
| 剂型 | Eye drops, solution |
|---|
| 上市许可持有人 | Bausch Health Ireland Limited
3013 Lake Drive, Citywest Business Campus
Dublin 24 - D24 PPT3 - Ierland |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) |
|---|
| 互认成员国 - 产品名称 | - Sweden (SE)
- Norway (NO)
- Finland (FI)
- Portugal (PT)
- Austria (AT)
- Romania (RO)
Lumobry 0,25 mg picături oftalmice, soluţie - Spain (ES)
- Ireland (IE)
- Czechia (CZ)
Lumobry - France (FR)
- Belgium (BE)
- Cyprus (CY)
Lumify eye drops, solution, 0.25 mg/ml - Denmark (DK)
- Croatia (HR)
- Germany (DE)
Lumobry 0,25 mg/ml Augentropfen, Lösung - Bulgaria (BG)
Lumobry 0.25mg/ml eye drops, solurtion - Hungary (HU)
Lumobry - Slovenia (SI)
- Slovakia (SK)
- Poland (PL)
Lumify - Italy (IT)
- Greece (GR)
|
|---|
| 许可日期 | 2022/08/02 |
|---|
| 最近更新日期 | 2024/03/13 |
|---|
| 药物ATC编码 | - S01GA Sympathomimetics used as decongestants
| 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|